Your browser doesn't support javascript.
loading
Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma.
Duchatel, Ryan J; Mannan, Abdul; Woldu, Ameha S; Hawtrey, Tom; Hindley, Phoebe A; Douglas, Alicia M; Jackson, Evangeline R; Findlay, Izac J; Germon, Zacary P; Staudt, Dilana; Kearney, Padraic S; Smith, Nathan D; Hindley, Kate E; Cain, Jason E; André, Nicolas; La Madrid, Andres Morales; Nixon, Brett; De Iuliis, Geoffry N; Nazarian, Javad; Irish, Kathleen; Alvaro, Frank; Eisenstat, David D; Beck, Alexander; Vitanza, Nicholas A; Mueller, Sabine; Morris, Jonathan C; Dun, Matthew D.
Afiliação
  • Duchatel RJ; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
  • Mannan A; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
  • Woldu AS; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
  • Hawtrey T; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
  • Hindley PA; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
  • Douglas AM; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
  • Jackson ER; School of Chemistry, University of New South Wales, Sydney, New South Wales, Australia.
  • Findlay IJ; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
  • Germon ZP; Jewells Medical Centre, Jewells, New South Wales, Australia.
  • Staudt D; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
  • Kearney PS; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
  • Smith ND; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
  • Hindley KE; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
  • Cain JE; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
  • André N; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
  • La Madrid AM; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
  • Nixon B; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
  • De Iuliis GN; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
  • Nazarian J; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
  • Irish K; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
  • Alvaro F; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
  • Eisenstat DD; Analytical and Biomolecular Research Facility, Advanced Mass Spectrometry Unit, University of Newcastle, Callaghan, New South Wales, Australia.
  • Beck A; Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
  • Vitanza NA; Sash Small Animal Specialist Hospital, Tuggerah, New South Wales, Australia.
  • Mueller S; Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Morris JC; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Dun MD; Department of Pediatric Oncology, La Timone Children's Hospital, AP-HM, Marseille, France.
Neurooncol Adv ; 3(1): vdab169, 2021.
Article em En | MEDLINE | ID: mdl-34988452
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Neurooncol Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Neurooncol Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália